GlassScriptPhysician profile
Jeffrey A Ascherman
NPI 1043236045
$5,846.18
in general payments reported to CMS, 2019-2025
27 companies · $1,859 in 2025
The $1,859 reported for 2025 was more than what 82% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470 · 2020: $233 · 2021: $623 · 2022: $1,265 · 2023: $709 · 2024: $686 · 2025: $1,859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,254.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,539.88 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $980.49 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Polynovo North America LLC | $784.40 | 2024-2025 | Novosorb Btm |
| Davol INC. | $592.95 | 2019-2025 | Phasix Mesh, Arista |
| Avita Medical Americas, LLC | $315.23 | 2025 | Recell, Permeaderm, Cohealyx |
| Solventum Corporation | $278.89 | 2025 | V.A.C. Granufoam, Prevena |
| Axogen | $223.52 | 2022-2025 | Axoguard Nerve Cap, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Rti Surgical, INC | $144.53 | 2023 | |
| Coopersurgical, INC. | $114.44 | 2020-2025 | Insorb |
| Ethicon US, LLC | $112.29 | 2019-2022 | |
| Checkpoint Surgical, INC | $99.13 | 2022 | |
| Kci USA, INC. | $93.84 | 2019 | |
| Abbvie INC. | $89.11 | 2024-2025 | |
| Sientra, INC. | $69.74 | 2021-2022 | |
| Convatec INC. | $59.97 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $55.34 | 2021-2024 | Gore Enform Preperitoneal Biomaterial |
| Musculoskeletal Transplant Foundation INC. | $49.26 | 2021-2022 | |
| Baxter Healthcare | $38.28 | 2025 | Tisseel |
| Kerecis Limited | $35.68 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Motiva USA, LLC | $29.14 | 2025 | |
| Innovation Technologies INC | $28.11 | 2022 | |
| Allergan, INC. | $28.09 | 2021 | |
| Bioventus LLC | $27.46 | 2022 | |
| Lifenet Health | $24.95 | 2023 | |
| Elutia, INC. | $15.88 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.58 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$45,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Ascherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.